Appen Limited

ASX:APX 주식 리포트

시가총액: AU$318.9m

Appen 향후 성장

Future 기준 점검 4/6

Appen (는) 각각 연간 73% 및 14.1% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 75.4% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 -3.7% 로 예상됩니다.

핵심 정보

73.0%

이익 성장률

75.40%

EPS 성장률

IT 이익 성장-4.7%
매출 성장률14.1%
향후 자기자본이익률-3.69%
애널리스트 커버리지

Low

마지막 업데이트30 Apr 2026

최근 향후 성장 업데이트

Recent updates

내러티브 업데이트 Apr 24

APX: 2026 Earnings Outlook Will Expose Risk In Elevated P/E

Analysts have updated their Appen fair value estimate from A$0.52 to A$0.59. This reflects adjusted assumptions for revenue growth, profit margin and future P/E, along with the application of a revised discount rate.
내러티브 업데이트 Apr 10

APX: Upgraded Outlook Will Rely On 2026 Earnings Guidance Delivery

Analysts have lifted Appen's implied fair value target from A$1.27 to A$1.79, reflecting updated views on revenue growth, profit margins, and a lower future P/E multiple in their models. What's in the News Appen issued group earnings guidance for fiscal 2026, giving investors clearer visibility on expected performance (Key Developments).
내러티브 업데이트 Mar 27

APX: Fiscal 2026 Guidance And Margin Outlook Will Support Long Term Upside

Analysts have lifted their price target for Appen to A$2.35, reflecting updated assumptions around slightly higher revenue growth, a modestly better profit margin and a lower future P/E multiple, offset by a marginally reduced discount rate. What's in the News Appen released group earnings guidance for fiscal 2026, giving investors a clearer view of management expectations for the medium term (company guidance).
내러티브 업데이트 Mar 12

APX: Fiscal 2026 Earnings Guidance Will Support Long Term Upside

Analysts have maintained their A$2.35 price target on Appen, with small tweaks to assumptions on discount rate, revenue growth, profit margin and future P/E contributing to a broadly unchanged view of fair value. What's in the News Appen issued group earnings guidance for fiscal 2026, with expected revenue in a range of $270 million to $300 million, giving investors a reference point for sizing the business over the next couple of years (Key Developments).
내러티브 업데이트 Feb 26

APX: Higher Profit Margin Outlook Will Support Long Term Upside

Analysts have lifted their price target on Appen from A$1.85 to A$2.35, citing revised assumptions around revenue growth, profit margins, and a lower future P/E multiple in their models. What's in the News Appen issued group earnings guidance for fiscal 2026, with expected revenue in the range of $270 million to $300 million (Company guidance, Key Developments).
내러티브 업데이트 Feb 12

APX: Higher Future P/E Assumptions Will Support Long Term Upside

Analysts have maintained their A$1.85 price target for Appen. A shift in their assumptions toward a higher discount rate, lower revenue growth and profit margins, and a much higher future P/E multiple explains why the target itself has not changed.
내러티브 업데이트 Jan 29

APX: Higher Margin Outlook Will Support Improved Long Term P/E Multiple

Analysts have lifted their price target on Appen from A$1.65 to A$1.85, citing updated assumptions for revenue growth, profit margins and a lower future P/E multiple as key drivers of the change. Valuation Changes Fair Value: Updated from A$1.65 to A$1.85, indicating a higher assessed value per share in the latest model.
분석 기사 Jan 08

There's Reason For Concern Over Appen Limited's (ASX:APX) Massive 30% Price Jump

Appen Limited ( ASX:APX ) shares have had a really impressive month, gaining 30% after a shaky period beforehand...
내러티브 업데이트 Aug 29

LLM And Generative AI Projects Will Secure A Bright Future

Despite a notable improvement in Appen’s net profit margin and a sharp decline in its future P/E ratio, analysts have significantly lowered their fair value estimate, with the consensus price target dropping from A$1.48 to A$1.27. Valuation Changes Summary of Valuation Changes for Appen The Consensus Analyst Price Target has significantly fallen from A$1.48 to A$1.27.
분석 기사 Aug 20

Appen Limited (ASX:APX) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough

ASX:APX 1 Year Share Price vs Fair Value Explore Appen's Fair Values from the Community and select yours Appen Limited...
분석 기사 Jun 11

Companies Like Appen (ASX:APX) Can Afford To Invest In Growth

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
분석 기사 May 14

Appen Limited (ASX:APX) Shares Fly 34% But Investors Aren't Buying For Growth

Those holding Appen Limited ( ASX:APX ) shares would be relieved that the share price has rebounded 34% in the last...
User avatar
새 내러티브 Apr 22

LLM And Generative AI Projects Will Secure A Bright Future

Strong growth in generative AI projects and strategic positioning in key markets imply significant revenue expansion and diversified income sources.
분석 기사 Mar 21

Appen Limited (ASX:APX) Looks Inexpensive After Falling 61% But Perhaps Not Attractive Enough

Appen Limited ( ASX:APX ) shareholders won't be pleased to see that the share price has had a very rough month...
분석 기사 Jan 04

Appen Limited's (ASX:APX) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Despite an already strong run, Appen Limited ( ASX:APX ) shares have been powering on, with a gain of 26% in the last...
분석 기사 Oct 15

Appen Limited (ASX:APX) Stock Rockets 44% As Investors Are Less Pessimistic Than Expected

Appen Limited ( ASX:APX ) shares have continued their recent momentum with a 44% gain in the last month alone. The...
분석 기사 Aug 31

Appen Limited's (ASX:APX) Shares Bounce 28% But Its Business Still Trails The Industry

Appen Limited ( ASX:APX ) shares have continued their recent momentum with a 28% gain in the last month alone. Not all...
분석 기사 Jul 30

Appen (ASX:APX) Will Have To Spend Its Cash Wisely

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
분석 기사 Jun 04

Appen Limited's (ASX:APX) Price Is Right But Growth Is Lacking

Appen Limited's ( ASX:APX ) price-to-sales (or "P/S") ratio of 0.3x might make it look like a buy right now compared to...
분석 기사 Apr 04

We're A Little Worried About Appen's (ASX:APX) Cash Burn Rate

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
분석 기사 Feb 29

There's No Escaping Appen Limited's (ASX:APX) Muted Revenues Despite A 66% Share Price Rise

Those holding Appen Limited ( ASX:APX ) shares would be relieved that the share price has rebounded 66% in the last...
분석 기사 Jan 15

The Market Doesn't Like What It Sees From Appen Limited's (ASX:APX) Revenues Yet As Shares Tumble 27%

To the annoyance of some shareholders, Appen Limited ( ASX:APX ) shares are down a considerable 27% in the last month...
분석 기사 Aug 24

When Should You Buy Appen Limited (ASX:APX)?

Appen Limited ( ASX:APX ), might not be a large cap stock, but it saw a double-digit share price rise of over 10% in...
분석 기사 May 15

Downgrade: Here's How Analysts See Appen Limited (ASX:APX) Performing In The Near Term

Today is shaping up negative for Appen Limited ( ASX:APX ) shareholders, with the analysts delivering a substantial...
분석 기사 May 10

Why Appen Limited (ASX:APX) Could Be Worth Watching

While Appen Limited ( ASX:APX ) might not be the most widely known stock at the moment, it received a lot of attention...
분석 기사 Apr 13

Are Investors Undervaluing Appen Limited (ASX:APX) By 21%?

Key Insights Using the 2 Stage Free Cash Flow to Equity, Appen fair value estimate is AU$3.54 Appen's AU$2.80 share...

이익 및 매출 성장 예측

ASX:APX - 애널리스트 향후 추정치 및 과거 재무 데이터 (USD Millions)
날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수
12/31/20283642430424
12/31/20273291920334
12/31/202628012224
12/31/2025233-22623N/A
9/30/2025229-22-312N/A
6/30/2025225-22-131N/A
3/31/2025230-21-130N/A
12/31/2024235-20-14-1N/A
9/30/2024242-56-25-11N/A
6/30/2024248-93-36-21N/A
3/31/2024261-105-39-22N/A
12/31/2023274-118-43-23N/A
9/30/2023309-196-30-6N/A
6/30/2023345-273-1711N/A
3/31/2023367-256-1315N/A
12/31/2022388-239-1018N/A
9/30/2022411-113632N/A
6/30/2022434122245N/A
3/31/2022440202749N/A
12/31/2021447293154N/A
9/30/2021428282449N/A
6/30/2021409271844N/A
3/31/2021411323154N/A
12/31/2020413364465N/A
9/30/2020411345169N/A
6/30/2020401315771N/A
3/31/2020354274355N/A
12/31/2019376293647N/A
9/30/201933530N/A44N/A
6/30/201932033N/A45N/A
3/31/201929131N/A39N/A
12/31/201825729N/A33N/A
9/30/201822022N/A24N/A
6/30/201818215N/A14N/A
3/31/201815813N/A12N/A
12/31/201713011N/A10N/A
9/30/201711711N/A12N/A
6/30/201710110N/A14N/A
3/31/2017939N/A12N/A
12/31/2016808N/A9N/A
9/30/2016818N/A9N/A
6/30/2016758N/A9N/A
3/31/2016707N/A6N/A
12/31/2015606N/A3N/A
9/30/2015504N/A3N/A
6/30/2015462N/A3N/A

애널리스트 향후 성장 전망

수입 대 저축률: APX 은 향후 3년 동안 수익을 낼 것으로 예상되며, 이는 절약률(3.6%)보다 빠른 성장으로 간주됩니다.

수익 vs 시장: APX (는) 향후 3년 동안 평균 시장 성장보다 높은 수익을 올릴 것으로 예상됩니다.

고성장 수익: APX 향후 3년 내에 수익을 낼 것으로 예상됩니다.

수익 대 시장: APX 의 수익(연간 14.1%)이 Australian 시장(연간 6.4%)보다 빠르게 성장할 것으로 예상됩니다.

고성장 매출: APX 의 수익(연간 14.1%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.


주당순이익 성장 예측


향후 자기자본이익률

미래 ROE: APX는 3년 뒤에도 수익성이 없을 것으로 전망됩니다.


성장 기업 찾아보기

기업 분석 및 재무 데이터 상태

데이터최종 업데이트 (UTC 시간)
기업 분석2026/05/07 22:04
종가2026/05/07 00:00
수익2025/12/31
연간 수익2025/12/31

데이터 소스

당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.

패키지데이터기간미국 소스 예시 *
기업 재무제표10년
  • 손익계산서
  • 현금흐름표
  • 대차대조표
분석가 컨센서스 추정치+3년
  • 재무 예측
  • 분석가 목표주가
시장 가격30년
  • 주가
  • 배당, 분할 및 기타 조치
지분 구조10년
  • 주요 주주
  • 내부자 거래
경영진10년
  • 리더십 팀
  • 이사회
주요 개발10년
  • 회사 공시

* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.

별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 스노우플레이크

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드YouTube 튜토리얼도 제공합니다.

Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.

산업 및 섹터 지표

산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.

분석가 소스

Appen Limited는 9명의 분석가가 다루고 있습니다. 이 중 4명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.

분석가기관
Josh KannourakisBarrenjoey Markets Pty Limited
Conor O’PreyCanaccord Genuity
Siraj AhmedCitigroup Inc